Life Sciences

OIG releases 2008 Work Plan

Pharma Compliance Alert, October 10, 2007

The OIG's recently-released 2008 Work Plan addresses a variety of topics related to Medicare Part D reimbursement.

The OIG plans to review:

  • Medicare Part D v. Medicare Part B average sales prices
  • Medicare Part D coordination of benefits with other prescription drug coverage
  • Potential fraudulent drug overutilization by dual-eligible beneficiaries under Medicare Part D
  • Medicare Part D explanation of benefits forms
  • Beneficiary complaints about Medicare prescription drug plans

The Work Plan also identifies a number of Food and Drug Administration (FDA) related items, such as assessing the oversight of off-label drug promotion, research misconduct by clinical investigators, and financial disclosure requirements for investigators.

Click here to read the Work Plan.

Most Popular

Related Articles